Back
Ocular Therapeutix, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
32
OCUL
Ocular Therapeutix, Inc.
Last Price:
$11.25
Seasonality Move:
15.66%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atOcular Therapeutix, Inc. Stock Forecast
-
Over the next 52 weeks, Ocular Therapeutix, Inc. has on average historically risen by 29.8% based on the past 11 years of stock performance.
-
Ocular Therapeutix, Inc. has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Ocular Therapeutix, Inc. Stock Undervalued?The current Ocular Therapeutix, Inc. [OCUL] share price is $11.26. The Score for OCUL is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
OCUL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Ocular Therapeutix, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Ocular Therapeutix, Inc. has on average historically risen by 29.8% based on the past 11 years of stock performance.
Ocular Therapeutix, Inc. Stock Rating
Sell
32
Ocular Therapeutix, Inc. (OCUL)
is a Sell
Is Ocular Therapeutix, Inc. overpriced?
-
Ocular Therapeutix, Inc. has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Ocular Therapeutix, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
ocutx.com
52-Week Data
52-Week High:
16.44
52-Week Low:
5.79
Prediction Charts
Market Cap:
2.4B
Price in USD:
11.26
Volume:
2.7M
Beta:
1.50
Technical Analysis
SMA50:
12.28
SMA100:
12.20
SMA200:
10.61
52-Wk Change:
26.94%
Stock Predictions
-
Is Ocular Therapeutix, Inc. stock public?Yes, Ocular Therapeutix, Inc. is a publicly traded company.
-
What is the Ocular Therapeutix, Inc. stock quote today?The Ocular Therapeutix, Inc. stock price is 11.26 USD today.
-
How to buy Ocular Therapeutix, Inc. stock online?You can buy Ocular Therapeutix, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-18 | 13.87 | 12.98 | 13.91 | 12.95 |
| Dec-19 | 12.99 | 12.56 | 13.21 | 12.27 |
| Dec-22 | 12.70 | 12.96 | 13.00 | 12.39 |
| Dec-23 | 12.86 | 12.74 | 13.06 | 12.65 |
| Dec-24 | 12.65 | 12.71 | 12.81 | 12.59 |
| Dec-26 | 12.66 | 12.56 | 12.75 | 12.48 |
| Dec-29 | 12.61 | 12.30 | 12.66 | 12.26 |
| Dec-30 | 12.24 | 12.20 | 12.45 | 12.15 |
| Dec-31 | 12.15 | 12.14 | 12.24 | 12.06 |
| Jan-5 | 11.87 | 11.55 | 11.98 | 11.31 |
| Jan-6 | 11.54 | 11.25 | 11.55 | 10.92 |
| Jan-7 | 11.41 | 11.50 | 11.65 | 11.20 |
| Jan-8 | 11.60 | 11.38 | 11.81 | 11.23 |
| Jan-9 | 11.41 | 11.26 | 11.57 | 11.14 |
Ocular Therapeutix, Inc. Earnings
Ocular Therapeutix, Inc. Earnings Report: Per Share Ocular Therapeutix, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Ocular Therapeutix, Inc. Forecast Revenue Growth
Ocular Therapeutix, Inc. Stock Analysis: Historical quarterly revenues per share for Ocular Therapeutix, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.12 per share.
* Ocular Therapeutix, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.